POSTMARKETING SURVEILLANCE - BEYOND MEDWATCH

被引：2

作者：

FAICH, GA

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1993年 / 270卷 / 18期

关键词：

D O I：

10.1001/jama.270.18.2180

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2180 / 2180

页数：1

共 50 条

[1] POSTMARKETING SURVEILLANCE
VOSS, S
HARRIS, F
[J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6948): : 194 - 194
[2] POSTMARKETING SURVEILLANCE
DENES, G
[J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1990, 132 (23): : 373 - 375
[3] MedWatch: an important instrument for postlicensing surveillance
Aledort, L. M.
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (07) : 1637 - 1637
[4] Postmarketing surveillance is needed
Srinivas, VR
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7456): : 51 - 51
[5] THE RATIONALE FOR A POSTMARKETING SURVEILLANCE
WESTERHOLM, B
[J]. HUMAN REPRODUCTION, 1987, 2 (01) : 41 - 44
[6] POSTMARKETING SURVEILLANCE IN SPAIN
CAPELLA, D
CABEZA, L
VIDAL, X
IBANEZ, L
LAPORTE, JR
[J]. ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 158 - 158
[7] THE DEMISE OF POSTMARKETING SURVEILLANCE
FLETCHER, AP
[J]. ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1995, 14 (01): : 7 - 9
[8] POSTMARKETING DRUG SURVEILLANCE
FELDMANN, EG
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (12) : R1 - R1
[9] Postmarketing surveillance of gabapentin
[J]. Reactions Weekly, 2002, 926 (1) : 5 - 5
[10] POSTMARKETING SURVEILLANCE STUDIES
FLETCHER, AP
[J]. BRITISH MEDICAL JOURNAL, 1992, 305 (6847): : 257 - 257